Viewing Study NCT01235702


Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2025-12-26 @ 2:33 AM
Study NCT ID: NCT01235702
Status: COMPLETED
Last Update Posted: 2010-11-05
First Post: 2010-11-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Metro Atlanta Heart Disease Study - II (MAHDS II)
Sponsor: Morehouse School of Medicine
Organization:

Study Overview

Official Title: Multiple CVD Risk Reduction in Adult African-Americans: A Pilot Study
Status: COMPLETED
Status Verified Date: 2003-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A 12-week treatment/control trial was implemented to assess the effects of a multi component lifestyle program on improvements in body mass index, weight, perceived stress and blood pressure in African American men and women who were at increased risk for cardiovascular disease. It was hypothesized that treatment group would experience significant improvements when compared to the control group.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: